Esophageal Institute, Allegheny Health Network, Pittsburgh, PA, USA.
Department of Surgery, Drexel University, Philadelphia, PA, USA.
Surg Endosc. 2023 May;37(5):3769-3779. doi: 10.1007/s00464-023-09878-y. Epub 2023 Jan 23.
Magnetic sphincter augmentation (MSA) erosion, disruption or displacement clearly requires device removal. However, up to 5.5% of patients without anatomical failure require removal for dysphagia or recurrent GERD symptoms. Studies characterizing these patients or their management are limited. We aimed to characterize these patients, compare their outcomes, and determine the necessity for further reflux surgery.
This is a retrospective review of 777 patients who underwent MSA at our institution between 2013 and 2021. Patients who underwent device removal for persistent dysphagia or recurrent GERD symptoms were included. Demographic, clinical, objective testing, and quality of life data obtained preoperatively, after implantation and following removal were compared between removal for dysphagia and GERD groups. Sub-analyses were performed comparing outcomes with and without an anti-reflux surgery (ARS) at the time of removal.
A total of 40 (5.1%) patients underwent device removal, 31 (77.5%) for dysphagia and 9 (22.5%) for GERD. After implantation, dysphagia patients had less heartburn (12.9-vs-77.7%, p = 0.0005) less regurgitation (16.1-vs-55.5%, p = 0.0286), and more pH-normalization (91.7-vs-33.3%, p = 0.0158). Removal without ARS was performed in 5 (55.6%) GERD and 22 (71.0%) dysphagia patients. Removal for dysphagia patients had more complete symptom resolution (63.6-vs-0.0%, p = 0.0159), freedom from PPIs (81.8-vs-0.0%, p = 0.0016) and pH-normalization (77.8-vs-0.0%, p = 0.0455). Patients who underwent removal for dysphagia had comparable symptom resolution (p = 0.6770, freedom from PPI (p = 0.3841) and pH-normalization (p = 0.2534) with or without ARS. Those who refused ARS with removal for GERD had more heartburn (100.0%-vs-25.0%, p = 0.0476), regurgitation (80.0%-vs-0.0%, p = 0.0476) and PPI use (75.0%-vs-0.0%, p = 0.0476).
MSA removal outcomes are dependent on the indication for removal. Removal for dysphagia yields excellent outcomes regardless of anti-reflux surgery. Patients with persistent GERD had worse outcomes on all measures without ARS. We propose a tailored approach to MSA removal-based indication for removal.
磁括约肌增强(MSA)的侵蚀、破裂或移位显然需要移除设备。然而,高达 5.5%的没有解剖失败的患者因吞咽困难或复发性胃食管反流病(GERD)症状而需要移除。目前对这些患者或其治疗的研究有限。我们旨在描述这些患者,比较他们的结果,并确定是否需要进一步的反流手术。
这是对我院 2013 年至 2021 年间接受 MSA 治疗的 777 例患者的回顾性研究。纳入因持续性吞咽困难或复发性 GERD 症状而接受器械移除的患者。比较吞咽困难组和 GERD 组术前、植入后和移除后,在人口统计学、临床、客观检查和生活质量数据方面的差异。在移除时是否进行抗反流手术(ARS)的情况下进行了亚分析。
共有 40 例(5.1%)患者接受了器械移除,其中 31 例(77.5%)因吞咽困难,9 例(22.5%)因 GERD。植入后,吞咽困难患者的烧心症状(12.9-vs-77.7%,p=0.0005)和反流症状(16.1-vs-55.5%,p=0.0286)更少,pH 值更正常(91.7-vs-33.3%,p=0.0158)。在 5 例(55.6%)GERD 和 22 例(71.0%)吞咽困难患者中,未行 ARS 就进行了器械移除。吞咽困难患者的症状完全缓解(63.6-vs-0.0%,p=0.0159)、无 PPI(81.8-vs-0.0%,p=0.0016)和 pH 值正常化(77.8-vs-0.0%,p=0.0455)的比例更高。在吞咽困难患者中,无论是否进行 ARS,移除后的症状缓解(p=0.6770)、无 PPI(p=0.3841)和 pH 值正常化(p=0.2534)情况相似。而对于 GERD 而进行移除且拒绝 ARS 的患者,烧心(100.0%-vs-25.0%,p=0.0476)、反流(80.0%-vs-0.0%,p=0.0476)和 PPI 使用(75.0%-vs-0.0%,p=0.0476)的比例更高。
MSA 移除的结果取决于移除的指征。吞咽困难的移除结果无论是否进行抗反流手术都非常出色。所有措施均无 ARS 的持续性 GERD 患者的预后更差。我们建议根据移除的指征,采用一种针对 MSA 移除的针对性方法。